A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: mericitabine; Drug: mericitabine; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: mericitabine; Drug: mericitabine; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Condition: Hepatitis C, ChronicInterventions: Drug: Copegus; Drug: Copegus; Drug: Pegasys; Drug: Pegasys; Drug: Placebo; Drug: mericitabine; Drug: mericitabine; Drug: telaprevirSponsor: Hoffmann-La RocheCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2011 Category: Research Source Type: clinical trials
TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy
Condition: Hepatitis CInterventions: Drug: TMC435; Drug: TVRSponsor: Janssen R&D IrelandCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2011 Category: Research Source Type: clinical trials
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: ribavirin; Drug: peginterferon alfa-2aSponsor: Vertex Pharmaceuticals IncorporatedCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials
